# Studies of Traditional Chinese Medicine Clinical Efficacy Evaluation Index

Study · id `cardio:ct-nct01502943` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01502943](<https://clinicaltrials.gov/study/NCT01502943>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01502943

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 480 participants.

## Technical summary

Registry record NCT01502943. Randomized; triple masking. Start 2011-05 (registry gives no type); primary completion 2011-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking
- Phase: Phase 4
- Enrolled: 480 participants (enrolled count; ClinicalTrials.gov record NCT01502943, source copy `cardio:ctgov-nct01502943-2012-01-02`, retrieved 2026-10-31)
- Start date: 2011-05 (registry gives no type) (ClinicalTrials.gov record NCT01502943, source copy `cardio:ctgov-nct01502943-2012-01-02`, retrieved 2026-10-31)
- Primary completion: 2011-12 (actual) (ClinicalTrials.gov record NCT01502943, source copy `cardio:ctgov-nct01502943-2012-01-02`, retrieved 2026-10-31)
- Completion: 2011-12 (actual) (ClinicalTrials.gov record NCT01502943, source copy `cardio:ctgov-nct01502943-2012-01-02`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT01502943, source copy `cardio:ctgov-nct01502943-2012-01-02`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01502943-2012-01-02`, retrieved 2026-10-31)

## The registry's words

- Brief title: Studies of Traditional Chinese Medicine Clinical Efficacy Evaluation Index
- Condition: Coronary Heart Disease
- Condition: Stable Angina Pectoris
- Intervention (Drug): Louxiangdan Tongxin granules
- Intervention (Drug): TCM granules placebo
- Intervention (Drug): Chixiangshen Tongxin granules
- Intervention (Drug): TCM granule placebo plus western basis treatment
- Intervention (Drug): Western basis treatment
- Lead sponsor: Liaoning University of Traditional Chinese Medicine
- Lead sponsor class: OTHER
- Collaborator: Ministry of Science and Technology of the People´s Republic of China
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Stable angina (`cardio:stable-angina`)
- Registry lists this organization as a collaborator: Ministry of Science and Technology of the People´s Republic of China (`cardio:org-ministry-of-science-and-technology-of-the-people-s-republic-dda658`)

## Provenance

Content hash: ae12150240b92c6e7f4e2ed149c8c2ed3f48331869de707ef906a9a7ee605e91
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
